1. Home >
  2. Abbott Laboratories Acquires Walk Vascular

M&A Deal Summary

Abbott Laboratories Acquires Walk Vascular

On September 2, 2021, Abbott Laboratories acquired medical products company Walk Vascular

Acquisition Highlights
  • This is Abbott Laboratories’ 18th transaction in the Medical Products sector.
  • This is Abbott Laboratories’ 26th transaction in the United States.
  • This is Abbott Laboratories’ 13th transaction in California.

M&A Deal Summary
Date 2021-09-02
Target Walk Vascular
Sector Medical Products
Buyer(s) Abbott Laboratories
Deal Type Add-on Acquisition

Target

Walk Vascular

Irvine, California, United States
Walk Vascular is a commercial-stage medical device company with a minimally invasive mechanical aspiration thrombectomy system designed to remove peripheral blood clots. Walk Vascular was founded in 2010 and is based in Irvine, California.

Search 204,969 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Abbott Laboratories

North Chicago, Illinois, United States
Category Company
Founded 1888
Sector Medical Products
Employees114,000
Revenue 40.1B USD (2023)
DESCRIPTION
Entrance to Abbott's corporate campus in Abbott Park, Illinois.
Entrance to Abbott's corporate campus in Abbott Park, Illinois.

Abbott Laboratories is a diversified, global provider of diagnostics, medical devices, nutrition and pharmaceuticals. Abbott Laboratories was incorporated in 1888 and is headquartered in North Chicago, Illinois.

DEAL STATS #
Overall 33 of 35
Sector (Medical Products) 18 of 20
Type (Add-on Acquisition) 33 of 35
State (California) 13 of 14
Country (United States) 26 of 28
Year (2021) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-07-07 STARLIMS Technologies

Hollywood, Florida, United States

STARLIMS Technologies is a provider of laboratory information management systems. STARLIMS Technologies was founded in 1986 and is based in Hollywood, Florida.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-02-08 CSI

St. Paul, Minnesota, United States

CSI is a medical device company focused on developing and commercializing minimally invasive treatment solutions for vascular disease. Its primary products include catheter-based platforms, such as the Stealth 360° peripheral artery disease (PAD) System, Diamondback 360° PAD System, and Diamondback Predator 360° PAD System that are used for the treatment of a range of plaque types in leg arteries above and below the knee. CSI was founded in 1989 and is based in St. Paul, Minnesota.

Buy $890M
Mergr

Product

Company

Legal